<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04557111</url>
  </required_header>
  <id_info>
    <org_study_id>Remote Care Study</org_study_id>
    <nct_id>NCT04557111</nct_id>
  </id_info>
  <brief_title>Remote Care for CIED Patients in Korea</brief_title>
  <official_title>Quality and Satisfaction in CIED Remote Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Vincent's Hospital, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Saint Vincent's Hospital, Korea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is for monitoring the quality and satisfaction of CIED patients who are naive with&#xD;
      remote device monitoring.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction measurement before and after remote monitoring</measure>
    <time_frame>1 year</time_frame>
    <description>Satisfaction measurement by questionnaire: Survey on telehealth patient experience(modified Korean version by YouMi Hwang,2020 from Bas-Villalobos, Form I) and Post remote monitoring satisfaction questionnaire, modified Korean version by YouMi Hwang,2020 from HoMASQ (Home Monitoring Acceptance and Satisfaction Questionnaire, Form II): Usually higher scores mean a worse outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Any changes in prescription or patient visit schedule</measure>
    <time_frame>1 year</time_frame>
    <description>Any changes in prescription or patient visit schedule based on remote monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Out patient clinic time consumption per patient</measure>
    <time_frame>1 year</time_frame>
    <description>Out patient clinic time consumption per patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in CIED parameters</measure>
    <time_frame>1 year</time_frame>
    <description>Changes in CIED parameters during remote monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any cardiocerebrovascular events, deaths</measure>
    <time_frame>1 year</time_frame>
    <description>Any cardiocerebrovascular events, deaths</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Admission for heart failure or any cardiovascular intervention</measure>
    <time_frame>1 year</time_frame>
    <description>Admission for heart failure or any cardiovascular intervention</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Arrhythmias, Cardiac</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>remote monitoring</intervention_name>
    <description>CIED monitoiring with remote monitoring device</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study includes Biotronic CIED implanted patients in St. Vincent's Hospital, Catholic&#xD;
        University of Korea, Republic of Korea. Study population are included if they are more than&#xD;
        20year old, followed up at outpatient clinic &gt; 6 months after CIED implantation, and are&#xD;
        literate and have perceptibility on questionnaire.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with Biotronic CIED implanted in St. Vincent's Hospital, Catholic University&#xD;
             of Korea, Republic of Korea&#xD;
&#xD;
          2. Patients who are literate and have perceptibility on questionnaire&#xD;
&#xD;
          3. Patients who followed up more than 6 months after CIED implantation&#xD;
&#xD;
          4. Patients with age of &gt;20 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with &lt; 2 outpatient clinic visits during &gt;6 months&#xD;
&#xD;
          2. Illiterate patients or inapprehensive of questionnaire&#xD;
&#xD;
          3. Patients with life expectancy of &lt;1 year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>YouMi Hwang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Suwon</city>
        <state>Kyonggi Do</state>
        <zip>16247</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 14, 2020</study_first_submitted>
  <study_first_submitted_qc>September 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2020</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saint Vincent's Hospital, Korea</investigator_affiliation>
    <investigator_full_name>You Mi Hwang</investigator_full_name>
    <investigator_title>Assistant Professor in Internal Medicine, Cardiology, Cardiac Electrophysiologist</investigator_title>
  </responsible_party>
  <keyword>pacemaker</keyword>
  <keyword>Implantable Cardioverter Defbrillator</keyword>
  <keyword>Cardiac resynchronization therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

